Ozempic Is About to Go on Sale

Even after Trump’s new deal, obesity drugs are still too expensive.

Novo Nordisk strikes US Medicare price deal

Novo Nordisk said on Wednesday it had agreed a price under the U.S. Medicare scheme for semaglutide, the active ingredient in ...
ConsumerAffairs

Medicare negotiates new prices for Ozempic and Wegovy

The Danish pharmaceutical giant Novo Nordisk has struck an agreement with the Centers for Medicare & Medicaid Services (CMS) ...

Searching 'weight' can bring up Ozempic in results. It's a drug advertising loophole

There are strict rules about what drug companies can say in TV or print ads. But a new study shows there's a lot more wiggle ...

Novo Nordisk challenges Pfizer to raise offer for obesity biotech Metsera

Danish company is battling with Pfizer for US biotech as they seek edge in growing market for weight-loss drugs ...

Novo Nordisk CFO outlines ‘ultimate defense’ against stock downgrades and lawsuits to retain weight-loss crown

The ultimate defense in our industry is in innovation,” Karsten Munk Knudsen told Fortune in an exclusive interview.